RK Pharma
Archis Pharma
Aktinos Pharma
CIN: U24119GJ2006FTC048777

Both sites have state of the art cGMP compliant facilities to handle full range pilot, small and large scale API manufacturing.
Manufacturing Capabilities - API
Key Highlights
  • Six multi-purpose manufacturing suites (Class ISO 8); batch size of 20g - 500Kg
  • Dedicated High Potency Manufacturing Suites to handle Cytotoxic molecules of band 4 & 5; batch size of up to 50Kg
  • Reactors with 10L - 10,000L variable batch sizes.
  • A sterile API Manufacturing block
  • Total volume of 500.000L with a combination of 60% MSGL & 40% SS reactors, supported by highly efficient ancillary utilities
  • Capable handling high pressure Amination and Reduction Reactions up to 100Bar; capacity of 100L
  • licensed capacity of 1000 metric tons across facilities
Apicore LLC